APA (7th ed.) Citation

Chen, X., Li, R., Qiu, Y., Lin, F., Chen, S., Li, X., . . . Fang, M. (2025). Corrigendum to "Design, synthesis, and biological evaluation of N-(2-amino-phenyl)-5-(4-aryl-pyrimidin-2-yl)amino)-1H-indole-2-carboxamide derivatives as novel inhibitors of CDK9 and class I HDACs for cancer treatment" [Bioorg. Chem. 162 (2025) 108577]. Bioorganic chemistry.

Chicago Style (17th ed.) Citation

Chen, Xiaohui, et al. Corrigendum to "Design, Synthesis, and Biological Evaluation of N-(2-amino-phenyl)-5-(4-aryl-pyrimidin-2-yl)amino)-1H-indole-2-carboxamide Derivatives as Novel Inhibitors of CDK9 and Class I HDACs for Cancer Treatment" [Bioorg. Chem. 162 (2025) 108577]. Bioorganic chemistry, 2025.

MLA (9th ed.) Citation

Chen, Xiaohui, et al. Corrigendum to "Design, Synthesis, and Biological Evaluation of N-(2-amino-phenyl)-5-(4-aryl-pyrimidin-2-yl)amino)-1H-indole-2-carboxamide Derivatives as Novel Inhibitors of CDK9 and Class I HDACs for Cancer Treatment" [Bioorg. Chem. 162 (2025) 108577]. Bioorganic chemistry, 2025.